Bilastine - CAS# 202189-78-4 enzyl)-N2 N2-dimethyl-N1-(pyridin-2-yl)ethane-1 2-diamine hydrochloride UNII-R1ZW9H43ZJ

UNII-R1ZW9H43ZJ

23)5-2)14(18)10-15(13)24-3/h9-10

21R)-7-ethylidene-4

induces apoptosis

7aH-cyclopenta[c]pyran-4-carboxylic acid

Bilastine - CAS# 202189-78-4 enzyl)-N2 N2-dimethyl-N1-(pyridin-2-yl)ethane-1 2-diamine hydrochloride UNII-R1ZW9H43ZJBilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives). It exerts its effect as a selective histamine H1 receptor antagonist, and has a potency similar to cetirizine and is superior to fexofenadine. It was developed in Spain by FAES Farma. Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but